Cointime

Cardiokine

company

About

Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of

  • 11 - 50

Highlights

Total Funding Amount
$87M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$37M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active

Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004 and is headquartered in Philadelphia, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$87M
Cardiokine has raised a total of $87M in funding over 2 rounds. Their latest funding was raised on May 1, 2006 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 1, 2006 Series B $50M 1 — — Detail
Apr 13, 2004 Series A $37M 1 Perseus-Soros Biopharmaceutical Fund — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cardiokine is funded by 1 investors. Perseus-Soros Biopharmaceutical Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Perseus-Soros Biopharmaceutical Fund — Series B
Cointime
เนื้อหา
บริษัท